Native & Reconstituted LipoproteinsControlled Labeling & Surface ConjugationParticle-Focused Purification & Characterization
We provide custom lipoprotein labeling and conjugation services for research teams studying lipid transport, receptor-mediated uptake, particle trafficking, cholesterol handling, macrophage biology, and lipoprotein-based carrier systems. Projects may involve native low-density lipoprotein (LDL), high-density lipoprotein (HDL), very-low-density lipoprotein (VLDL), modified LDL, reconstituted HDL, apolipoproteins, or customer-defined lipid–protein particles.
Our workflow integrates lipoprotein format review, label placement strategy, reaction or membrane-insertion optimization, purification, free-label removal, particle characterization, and function-relevant verification. Depending on the experimental objective, lipoproteins can be prepared with fluorescent dyes, biotin, affinity handles, small-molecule reporters, or orthogonal reactive groups. Projects can also be coordinated with broader protein conjugation services, lipid conjugation, or fluorescence labeling requirements.
Lipoproteins are dynamic assemblies rather than simple soluble proteins. Their biological behavior depends on the combined structure of the apolipoprotein component, amphipathic surface monolayer, hydrophobic lipid core, particle size, surface charge, and lipid composition. A labeling method that works well for an isolated protein or synthetic lipid may alter a lipoprotein particle when applied without considering this hybrid architecture.
Common project failures include excessive dye loading, fluorescence self-quenching, free dye contamination, aggregation after purification, modification of receptor-interacting apolipoprotein regions, loss of particle-associated signal, uncontrolled label transfer, and inconsistent uptake between batches. Modified LDL projects introduce additional variables because oxidation or acetylation state can influence both particle properties and cellular recognition.
A project-specific strategy helps researchers select whether the label should be inserted into the lipid region, loaded into the hydrophobic core, coupled to accessible apolipoprotein residues, or introduced through a preinstalled orthogonal handle. Label amount, linker length, solvent exposure, reaction pH, purification route, buffer composition, and storage conditions are evaluated together to produce a conjugate that is measurable without unnecessarily compromising particle integrity or the intended biological interaction.
Lipophilic dyes, reactive fluorophores, biotin reagents, and linker-bearing molecules can change particle size, surface charge, lipid packing, or apolipoprotein conformation. We select labeling conditions according to the particle type and intended readout rather than applying a generic protein-labeling protocol.
Random modification of accessible lysines or other residues may affect apolipoprotein-mediated interactions. This is especially important for LDL receptor uptake, scavenger-receptor studies, and HDL interaction experiments. Label density and conjugation route are therefore controlled with the functional objective in mind.
Unbound or weakly associated fluorescent material can produce high background, nonspecific cellular staining, or misleading uptake data. Purification is planned around label chemistry and lipoprotein size so free label is removed without exposing the particle to unnecessarily disruptive conditions.
Native lipoproteins can vary in size, lipid composition, apolipoprotein content, and modification state. A single fluorescence measurement cannot establish conjugate quality. We combine label analysis with particle-focused measurements and, where requested, function-relevant comparisons.
Service packages are configured according to the lipoprotein format, label or payload, downstream assay, required analytical depth, and available starting material. We can work with customer-supplied particles or discuss preparation routes for defined research formats.
Scope: Technical assessment of native LDL, HDL, VLDL, modified LDL, reconstituted HDL, purified apolipoproteins, or custom lipid–protein particles.
Deliverables and value: A project-specific labeling plan defining the proposed chemistry, target label range, purification approach, analytical package, controls, and decision criteria before experimental work begins.
Scope: Fluorescent labeling of LDL, HDL, modified LDL, VLDL, reconstituted lipoproteins, and related lipid–protein assemblies for microscopy, flow-based analysis, uptake assays, or trafficking studies.
Deliverables and value: Purified fluorescent lipoprotein, labeling and optical data, recommended handling conditions, and optional comparison of multiple labeling levels or chemistries.
Scope: Covalent attachment of dyes, linkers, affinity groups, small molecules, or reactive handles to apoA-I, apoE, apoB-containing particles, or other compatible apolipoprotein systems.
Deliverables and value: Defined conjugation conditions, purified product, evidence of label attachment, and particle-integrity data selected for the project. Related chemistry can be coordinated with our protein labeling method development capabilities.
Scope: Preparation of biotinylated or affinity-tagged lipoproteins for capture, immobilization, interaction analysis, pull-down workflows, or assay-reagent development.
Deliverables and value: Purified affinity-labeled lipoprotein with incorporation and particle-quality data. Broader reagent options are available through our biotinylation services.
Scope: Research preparation or labeling of chemically modified lipoprotein formats, including oxidized LDL, acetylated LDL, and customer-defined comparator particles.
Deliverables and value: Native and/or modified research particles, preparation records, selected modification indicators, and recommendations for storage and experimental handling. The degree of modification and functional testing are defined for each project rather than assumed from a standard treatment.
Scope: Removal of free label, solvent, unreacted reagent, low-molecular-weight byproducts, and unstable particle species after lipoprotein labeling or conjugation.
Deliverables and value: A purified conjugate accompanied by analytical results that help determine whether it is suitable for the planned assay rather than merely confirming that fluorescence or biotin is present.
Particle type determines which labeling chemistries, purification methods, and quality attributes are most relevant. The following table provides a practical starting point; final conditions depend on the source material and experimental objective.
| Lipoprotein Format | Common Research Objective | Labeling Considerations | Useful Analytical Outputs |
| Native LDL | LDL-receptor uptake, intracellular trafficking, competition, and lipid-delivery research | ApoB accessibility, receptor-interacting regions, lipid-core integrity, oxidation control, and free-dye removal | Particle size, aggregation profile, label incorporation, optical properties, and optional receptor-dependent uptake comparison |
| Oxidized or Acetylated LDL | Scavenger-receptor uptake, macrophage lipid accumulation, and modified-lipoprotein research | Modification state must be considered together with fluorescent loading because both can alter charge and cellular recognition | Particle characteristics, modification-related measurements, free-label assessment, and optional macrophage uptake testing |
| Native HDL | HDL binding, particle trafficking, lipid exchange, and cholesterol-handling studies | Smaller particle size, exchangeable apolipoproteins, dye redistribution, and potential changes to apoA-I interactions | Size distribution, label association, apolipoprotein profile, fluorescence behavior, and stability observations |
| Reconstituted HDL | Controlled composition studies, carrier evaluation, probe incorporation, and structure–function research | Lipid composition, apoA-I-to-lipid ratio, assembly route, cargo solubility, and particle-size control | Assembly profile, size and dispersity, label or cargo incorporation, composition data, and storage behavior |
| VLDL or Triglyceride-Rich Particles | Lipolysis, lipid transport, receptor interaction, and particle-remodeling research | Larger size, triglyceride-rich core, particle heterogeneity, and sensitivity to sample handling | Particle-size profile, label retention, composition-related measurements, and handling-stability data |
| Apolipoprotein–Lipid Complexes | Mechanistic binding studies, controlled assembly, linker evaluation, and custom particle development | Protein labeling can be performed before or after assembly depending on whether site accessibility or particle incorporation is the priority | Protein identity, conjugation evidence, assembly profile, label ratio, and particle characterization |
Labeling-route selection depends on what the signal is intended to represent. A lipid-associated dye may report particle lipid or membrane transfer, while a covalently labeled apolipoprotein may be more appropriate when tracking the protein component. Dual-label designs may be considered when lipid and apolipoprotein behavior need to be distinguished.
| Labeling Strategy | Label Location | Suitable Uses | Key Development Considerations |
| Lipophilic Dye Insertion | Lipid surface region or hydrophobic particle environment | Cellular uptake, microscopy, flow-based detection, and particle-trafficking experiments | Dye-to-particle ratio, self-quenching, solvent tolerance, label transfer, free-dye background, and storage stability |
| Fluorescent Lipid Incorporation | Particle phospholipid layer or reconstituted lipid mixture | Controlled particle assembly, lipid exchange studies, membrane interaction, and multiplex designs | Compatibility of the labeled lipid with particle composition, acyl-chain behavior, fluorophore location, and molar incorporation level |
| Hydrophobic Core Loading | Neutral-lipid or cholesteryl-ester-rich particle core | Tracking of hydrophobic reporters, cargo-association studies, and carrier-development research | Cargo solubility, leakage, particle remodeling, loading reproducibility, and distinction between encapsulated and externally associated material |
| NHS Ester Coupling | Accessible primary amines on apolipoproteins | Covalent fluorescent labeling, biotinylation, affinity tagging, and linker installation | Reaction pH, competing amines, modification density, hydrolysis, and possible disturbance of receptor-interacting protein regions |
| Thiol-Selective Coupling | Accessible native or introduced sulfhydryl groups | More controlled protein labeling, linker attachment, and dual-functional particle construction | Thiol availability, reduction conditions, disulfide integrity, maleimide stability, and prevention of particle crosslinking |
| Click-Enabled Labeling | Prefunctionalized apolipoprotein, lipid, or cargo component | Orthogonal labeling, multifunctional particles, dual-label systems, and modular probe construction | Handle-installation route, catalyst compatibility, spacer design, reaction accessibility, and removal of excess click reagent |
| Biotin or Affinity Tagging | Apolipoprotein surface or lipid-anchored tag | Capture assays, immobilization, pull-down studies, binding analysis, and reagent development | Tag accessibility, multivalent bridging, steric effects, linker length, and compatibility with the selected capture surface |
Fluorescent lipid components can also be sourced or prepared through related fluorescently labeled lipid capabilities when a defined labeled phospholipid or lipid anchor is required for particle assembly.
An appropriate data package should assess both the label and the lipoprotein particle. The analytical plan is scaled to the project stage, material quantity, particle format, and intended experimental decision.
| Quality Attribute | Possible Method | Development Question | Typical Output |
| Particle Size & Dispersity | DLS, particle-sizing methods, SEC profile, or microscopy where appropriate | Did labeling or purification increase particle size or produce aggregates? | Comparative size distribution and aggregation observations |
| Surface Characteristics | Zeta potential or related charge-sensitive measurements | Did conjugation or chemical modification produce a substantial surface-state change? | Comparative surface-charge data and formulation observations |
| Label Incorporation | Absorbance, fluorescence, labeled-component quantification, or depletion analysis | How much label is associated with the purified particle preparation? | Label-to-protein, label-to-lipid, or relative incorporation estimate, depending on the system |
| Free Label Removal | Chromatographic fraction analysis, filtration comparison, dialysis endpoint, or fluorescence profile | Is the detected signal particle-associated rather than dominated by unbound material? | Purification profile and residual free-label assessment |
| Optical Performance | Absorbance and emission measurements | Is the label detectable in the intended channel without excessive quenching or spectral interference? | Spectral data, relative fluorescence response, and instrument-channel guidance |
| Apolipoprotein Integrity | Electrophoretic, chromatographic, immunochemical, or mass-based methods as appropriate | Did processing cause fragmentation, crosslinking, or substantial changes to the protein component? | Comparative protein profile and integrity observations |
| Particle Composition | Protein, phospholipid, cholesterol, triglyceride, or other composition-related assays | Does the processed sample retain the composition required for the study? | Selected component measurements or comparative composition ratios |
| Functional Performance | Uptake, binding, competition, capture, efflux-related, or application-specific testing | Does the labeled particle still support the intended experimental interaction? | Comparative response against an unlabeled, differently labeled, or modified control |
| Handling Stability | Short-term storage, freeze–thaw, light exposure, buffer, or incubation-condition comparison | Which conditions maintain acceptable particle and signal behavior during the planned workflow? | Handling recommendations and observed operating window |
Our workflow is designed to connect the chemistry to the biological question. Each stage addresses a different source of variability, from starting-particle quality through signal interpretation.

We clarify the lipoprotein type, source material, intended receptor or cell model, detection platform, desired label, controls, and required analytical depth. This establishes what the signal must represent and which particle properties need to be preserved.
The starting buffer, concentration, lipid composition, apolipoprotein features, available functional groups, and sensitivity to solvents or oxidation are reviewed. A lipid-associated, protein-directed, core-loading, or orthogonal conjugation route is then selected.
Candidate label ratios, reaction conditions, incubation times, and formulation parameters are screened where appropriate. The aim is to identify a usable labeling window rather than maximizing signal at the expense of particle quality.
Free dye, unreacted reagent, solvent, and low-molecular-weight byproducts are removed using a method matched to particle size and stability. The product is transferred into a suitable working or storage buffer when required.
Label incorporation is evaluated together with particle-related attributes such as size, aggregation, optical behavior, protein integrity, or composition. Optional functional comparisons are used when uptake, binding, or capture performance is central to the project.
Final materials are delivered with a project summary, selected analytical results, handling recommendations, and recorded processing conditions. These records support experimental planning, repeat builds, or the next optimization cycle.
Label selection, chemistry, solvent exposure, purification, and storage are planned around the combined lipid–protein architecture rather than treating lipoproteins as ordinary soluble proteins.

We distinguish lipid-associated, core-loaded, apolipoprotein-coupled, and affinity-tagged designs so the final signal is better aligned with the component or interaction the experiment is intended to track.
Free-label removal and buffer exchange are considered during method design, reducing the risk that a successful labeling reaction becomes unusable because the product cannot be purified without aggregation or signal loss.
Analytical options are selected to answer practical project questions: whether the label is particle-associated, whether the particle changed, and whether the material remains suitable for the intended research workflow.
Whether you need fluorescent LDL for an uptake assay, labeled modified LDL for macrophage research, biotinylated lipoproteins for a capture workflow, or a custom reconstituted HDL construct, we can develop a labeling and characterization plan around your starting material and experimental readout.
Provide the lipoprotein type, source, available quantity, buffer, preferred label, detection platform, and intended application so the project can be evaluated for chemistry compatibility, purification feasibility, and suitable quality controls. Contact our scientific team to request a project-specific proposal.
Projects may involve native LDL, HDL, VLDL, oxidized LDL, acetylated LDL, reconstituted HDL, purified apolipoproteins, or customer-defined lipid-protein particles. Feasibility depends on the source material, concentration, buffer, stability, and intended modification.
The choice depends on what the experiment needs to track. Lipid-associated labels are useful for following the particle lipid component, while covalent apolipoprotein labels are better suited to tracking the protein component. Dual-label approaches may help distinguish lipid transfer from whole-particle or protein trafficking.
Yes. Excessive dye loading, random modification of apolipoprotein residues, aggregation, oxidation, or major surface-charge changes may alter particle behavior. Label density, reaction conditions, purification, and function-relevant controls should therefore be included in method development.
Possible options include lipophilic carbocyanine dyes such as DiI-, DiO-, DiD-, or DiR-type probes, fluorescent lipid analogs, BODIPY-related components, and protein-reactive fluorophores. Selection depends on the lipoprotein format, instrument channels, required wavelength, photostability, and whether the lipid or protein component should be tracked.
Depending on particle size and dye chemistry, purification may use size-exclusion separation, dialysis, desalting, centrifugal processing, or another particle-compatible approach. The selected method should remove unbound material without causing substantial aggregation or loss of particle-associated label.
